Skip to content

SelectSecure 3830 Lead Imaging

SelectSecure 3830 Lead Imaging

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03941275
Enrollment
51
Registered
2019-05-07
Start date
2019-05-24
Completion date
2021-11-15
Last updated
2022-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Diseases

Brief summary

This study is designed to collect high-quality shoulder and intracardiac bi-plane fluoroscopic images during two standard arm motions on patients implanted with a market released SelectSecure 3830 lead for the purposes of developing a fracture reliability model.

Interventions

DIAGNOSTIC_TESTBi-plane fluoroscopy

In vivo acquisition of biplane cine radiographic images of the market released Medtronic SelectSecure 3830 pacing lead

Sponsors

Medtronic Cardiac Rhythm and Heart Failure
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients who are at least 18 years of age * Patient has a pacing, ICD or CRT system incorporating at least one SelectSecure 3830 lead in the right atrium or right ventricle * Patients able and willing to attend imaging session * Patients able and willing to give informed consent * Pacing capture threshold and pacing impedance of the lead are within normal range at the time of enrollment * Patient must be able to accomplish arm flexion and adduction past 90 degrees

Exclusion criteria

* Subjects who require a legally authorized representative to obtain consent * Subjects with

Design outcomes

Primary

MeasureTime frameDescription
Collect high quality shoulder and intracardiac bi-plane fluoroscopic cine images of the SelectSecure 3830 pacing lead.approximately 30 minutesFluoroscopic cine images will be collected in conjunction with a specialized calibration object. When imaging data is processed and analyzed it will characterize the time-varying lead shape changes.

Secondary

MeasureTime frameDescription
Acquire accelerometer-based motion dataapproximately 30 minutesDuring fluoroscopy of the two standard arm motions, accelerometer-based motion data will be collected which will allow matching of arm position with lead shape based on the fluoroscopic images.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026